(Q58181716)

Julia Costa

2

0 references

Philip Van Damme

Philip Van Damme

12

0 references

Vincenzo Silani

Vincenzo Silani

9

0 references

Pamela Shaw

Pamela Shaw

8

0 references

Mamede de Carvalho

3

Mamede de Carvalho

0 references

Albert C. Ludolph

13

Albert Ludolph

0 references

Wim Robberecht

7

Magdalena Kuźma-Kozakiewicz

Wim Robberecht

0 references

5

Magdalena Kuzma-Kozakiewicz

0 references

Hayrettin Tumani

11

Hayrettin Tumani

0 references

Markus Otto

14

Markus Otto

0 references

author name string

Stefan Lehnert

1

0 references

Claudia Morelli

6

0 references

Petra Steinacker

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

10

0 references

publication date

28 February 2014

0 references

published in

0 references

volume

15

0 references

issue

5-6

0 references

page(s)

344-350

0 references

cites work

Comparison of sporadic and familial disease amongst 580 cases of motor neuron disease

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2014.884592

Amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2014.884592

Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2014.884592

CSF markers in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2014.884592

Identification of potential CSF biomarkers in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2014.884592

Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2014.884592

Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2014.884592

1H-NMR-based metabolomic profiling of CSF in early amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2014.884592

Monitoring CSF proteome alterations in amyotrophic lateral sclerosis: obstacles and perspectives in translating a novel marker panel to the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2014.884592

CSF glial markers correlate with survival in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2014.884592

Amyotrophic lateral sclerosis: disease stage related changes of tau protein and S100 beta in cerebrospinal fluid and creatine kinase in serum

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2014.884592

Tau levels do not influence human ALS or motor neuron degeneration in the SOD1G93A mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2014.884592

Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2014.884592

Biomarkers in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2014.884592

Beta-amyloid 42 accumulation in the lumbar spinal cord motor neurons of amyotrophic lateral sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2014.884592

Axonal damage markers in cerebrospinal fluid are increased in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2014.884592

Onset and progression in inherited ALS determined by motor neurons and microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2014.884592

Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2014.884592

Progranulin (PGRN) expression in ALS: an immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2014.884592

Microglial upregulation of progranulin as a marker of motor neuron degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2014.884592

A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2014.884592

β-amyloid triggers ALS-associated TDP-43 pathology in AD models

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2014.884592

Intracellular amyloid beta interacts with SOD1 and impairs the enzymatic activity of SOD1: implications for the pathogenesis of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2014.884592

Decreased cystatin C immunoreactivity in spinal motor neurons and astrocytes in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2014.884592

Cystatin C: a candidate biomarker for amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2014.884592

Truncated cystatin C in cerebrospiral fluid: Technical [corrected] artefact or biological process?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2014.884592

Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2014.884592

Progranulin Leu271LeufsX10 is one of the most common FTLD and CBS associated mutations worldwide.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2014.884592

Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2014.884592

Progranulin mutations in ubiquitin-positive frontotemporal dementia linked to chromosome 17q21.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2014.884592

Mutations in progranulin gene: clinical, pathological, and ribonucleic acid expression findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2014.884592

Progranulin plasma levels as potential biomarker for the identification of GRN deletion carriers. A case with atypical onset as clinical amnestic Mild Cognitive Impairment converted to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2014.884592

Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2014.884592

Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2014.884592

Serum biomarker for progranulin-associated frontotemporal lobar degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2014.884592

Identification of monocyte chemoattractant protein-1 in senile plaques and reactive microglia of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2014.884592

Hypoxic-ischemic injury induces monocyte chemoattractant protein-1 expression in neonatal rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2014.884592

Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2014.884592

MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2014.884592

Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2014.884592

Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2014.884592

Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2014.884592

Short commentary on ‘a consensus protocol for the standardization of cerebrospinal fluid collection and biobanking’

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F21678421.2014.884592